Company intelligence / Profile preview

Eurocor

Bonn, North Rhine-Westphalia, Germanyeurocor.de ↗

Ownership: Private
Employees: ~26
Development stage: Other

Overview

Eurocor specializes in the research, development, and manufacture of interventional cardiovascular and endovascular treatment devices. Their products include innovative coronary stent technologies and drug-coated balloon catheters for minimally invasive cardiovascular and peripheral surgery. The company’s devices are used globally with over 7.8 million patients treated[1][2]. Clinical results are not detailed in public sources but the company is established as a commercial supplier.

Therapeutic areas: Cardiovascular
Modalities: DeviceDrug-coated balloon catheterStent
Industry: Surgical Medical Devices

Partnerships

Biosensors International Group (licensing agreement for drug-eluting balloon technology)

Beyond the preview

Go deeper on Eurocor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eurocor.

Explore the full profile